Pharmacovigilance Scientist 2 (Safety Aggregate Report Specialist 2)
11/09/2026,
IQVIA
Cape Town, South Africa
Scientist | Pharmacovigilance
Medical Laboratory Scientist - PRN
11/13/2026,
MedStar Health
Baltimore, MD
Medical Laboratory Scientist | Laboratory
Pharmacovigilance Scientist 2 (Safety Aggregate Report Specialist 2)
11/09/2026,
IQVIA
Belgrade, Serbia
Scientist | Pharmacovigilance
Associate Director Medical Science Liaison - East
11/09/2026,
IQVIA
Philadelphia, PA
Medical Affairs
Medical Director, Global Medical Affairs - Lung Cancer
11/13/2026,
Takeda Pharmaceutical Company Limited
Boston, MA
Medical Affairs | Medical Director | Medical Affairs
Pharmacovigilance Scientist 2 (Safety Aggregate Report Specialist 2)
11/08/2026,
IQVIA
New Cairo City, Cairo Governorate, Egypt
Scientist | Pharmacovigilance
Medical Laboratory Scientist III (Microbiology)
11/13/2026,
Johns Hopkins Healthcare
Baltimore, MD
Medical Laboratory Scientist | Laboratory | Microbiology
Clinical Trials Medical Science Liaison (MSL) – Oncology
11/09/2026,
IQVIA
Sydney NSW, Australia
Clinical Trials | Medical Affairs | Clinical Trials | Oncology
Biomedical Technician
11/13/2026,
Fresenius Medical Care
Louisville, KY
Biomedical Technician | Technician
Recruiter, Medical Sales & Medical Affairs
11/08/2026,
IQVIA
Prague, Czechia
Medical Affairs | Recruiter | Medical Affairs
Senior Principal Medical Science Liaison Spec
11/13/2026,
Medtronic
Mounds View, MN 55112
Medical Affairs
Pharmacovigilance Scientist 2 (Safety Aggregate Report Specialist 2)
11/08/2026,
IQVIA
Centurion, South Africa
Scientist | Pharmacovigilance
Substance Use Epidemiologist, Bureau of Alcohol and Drug Use
11/13/2026,
City of New York
New York, NY
Epidemiologist